医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2015年
2期
71-72
,共2页
人参麦冬提取物%冠状动脉造影术%对比剂肾病
人參麥鼕提取物%冠狀動脈造影術%對比劑腎病
인삼맥동제취물%관상동맥조영술%대비제신병
Ginseng ophiopogon japonicus extract%Coronary angiography%Contrast medium nephropathy
目的:观察人参麦冬提取物干预冠状动脉造影术对比剂肾病的临床研究。方法:纳入冠状动脉造影术患者100例,随机分为常规治疗组(n=50)和人参麦冬提取物干预组(n=50),各组患者在冠状动脉造影术前、后予常规药物治疗,人参麦冬提取物干预组在此基础上,于冠状动脉造影术前3天至术后7天加用人参麦冬提取物干预,每天一次;检测各组患者血清肌酐(Scr)、肾小球滤过率估测值(eGFR)在冠脉造影前后改变。结果:人参麦冬提取物干预组血清肌酐(Scr)、肾小球滤过率估测值(eGFR)的变化明显低于常规治疗组(P<0.01)。结论:人参麦冬提取物对冠状动脉造影术中的肾脏具有保护作用,明显减少对比剂肾病的发生。
目的:觀察人參麥鼕提取物榦預冠狀動脈造影術對比劑腎病的臨床研究。方法:納入冠狀動脈造影術患者100例,隨機分為常規治療組(n=50)和人參麥鼕提取物榦預組(n=50),各組患者在冠狀動脈造影術前、後予常規藥物治療,人參麥鼕提取物榦預組在此基礎上,于冠狀動脈造影術前3天至術後7天加用人參麥鼕提取物榦預,每天一次;檢測各組患者血清肌酐(Scr)、腎小毬濾過率估測值(eGFR)在冠脈造影前後改變。結果:人參麥鼕提取物榦預組血清肌酐(Scr)、腎小毬濾過率估測值(eGFR)的變化明顯低于常規治療組(P<0.01)。結論:人參麥鼕提取物對冠狀動脈造影術中的腎髒具有保護作用,明顯減少對比劑腎病的髮生。
목적:관찰인삼맥동제취물간예관상동맥조영술대비제신병적림상연구。방법:납입관상동맥조영술환자100례,수궤분위상규치료조(n=50)화인삼맥동제취물간예조(n=50),각조환자재관상동맥조영술전、후여상규약물치료,인삼맥동제취물간예조재차기출상,우관상동맥조영술전3천지술후7천가용인삼맥동제취물간예,매천일차;검측각조환자혈청기항(Scr)、신소구려과솔고측치(eGFR)재관맥조영전후개변。결과:인삼맥동제취물간예조혈청기항(Scr)、신소구려과솔고측치(eGFR)적변화명현저우상규치료조(P<0.01)。결론:인삼맥동제취물대관상동맥조영술중적신장구유보호작용,명현감소대비제신병적발생。
Objective Observe ginseng extracts from radix ophiopogonis intervention coronary angiography contrast medium kidney disease clinical research.Methods Into 100 patients with coronary artery angiography were randomly divided into conventional treatment group (n=50) and ginseng extracts from radix ophiopogonis intervention group (n=50), intervention group in coronary angiography before 3 days to 7 days after added with ginseng extracts from radix ophiopogonis intervention, once a day.Results Intervention group, serum creatinine (Scr), and estimated glomerular filtration rate (eGFR) changes significantly lower than the routine treatment group (P < 0.01).Conclusions Ginseng extracts from radix ophiopogonis on the kidney plays a protective role in coronary artery angiography, significantly reduce the happening of the contrast medium nephropathy.